Chenyang Shi

Direktor/Vorstandsmitglied bei GENSCRIPT BIOTECH CORPORATION

56 Jahre

Consumer Services

Health Technology

Commercial Services

Aktive Positionen von Chenyang Shi

Unternehmen	Position	Beginn	Ende
GENSCRIPT BIOTECH CORPORATION	Direktor/Vorstandsmitglied	12.04.2024	-
GENSCRIPT BIOTECH CORPORATION	Independent Dir/Board Member	12.04.2024	-

Unternehmen	Position	Beginn	Ende
NuProbe USA, Inc. NuProbe USA, Inc. Miscellaneous Commercial ServicesCommercial Services NuProbe USA, Inc. engages in the development of ultra-sensitive and multiplexed platform with reagents for non-invasive nucleic acid profiling and diagnostics. The firm offers VarTrace EGFR Assay, VarTrace BFAR Assay, and VarTrace AML multi-gene panel. The company was founded by Peng Yin, David Yu Zhang, and Victor Chenyang Shi in 2016 and is headquartered in Cambridge, MA.	Direktor/Vorstandsmitglied	01.01.2016	-
	Vorstandsvorsitzender	01.01.2016	-
	Gründer	01.01.2016	-
	Präsident	01.01.2016	-

Rochester Christian University	Doctorate Degree
University of Science & Technology of China	Undergraduate Degree

International

Vereinigte Staaten	3
China	3

Operativ

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
GENSCRIPT BIOTECH CORPORATION	Health Technology

Private Unternehmen	1
NuProbe USA, Inc. NuProbe USA, Inc. Miscellaneous Commercial ServicesCommercial Services NuProbe USA, Inc. engages in the development of ultra-sensitive and multiplexed platform with reagents for non-invasive nucleic acid profiling and diagnostics. The firm offers VarTrace EGFR Assay, VarTrace BFAR Assay, and VarTrace AML multi-gene panel. The company was founded by Peng Yin, David Yu Zhang, and Victor Chenyang Shi in 2016 and is headquartered in Cambridge, MA.	Commercial Services

Private Unternehmen

Commercial Services